Online Only Articles

Inclusion and response criteria for clinical trials in relapsed/refractory acute lymphoblastic leukemia and usefulness of historical control trials

University Hospital, Goethe University, Frankfurt, Germany
Hopital Saint-Louis, Paris, France
UOC Ematologia, Ospedale dell’Angelo, Mestre-Venezia, Italy
Dana-Farber Cancer Institute, Boston, MA, USA
University Hospital, Brno, Czech Republic, Barcelona, Spain
ICO-Hospital Germans Trias I Pujol, Jose Carreras Research Institute, Barcelona, Spain
Vol. 102 No. 3 (2017): March, 2017